Blackstone Pours $400M Into Chinese Pharma Co.
Blackstone Group LP has agreed to invest $400 million in Hong Kong-listed YiChang HEC ChangJiang Pharmaceutical Co. as the drug company looks to acquire new drugs and other products and the...To view the full article, register now.
Already a subscriber? Click here to view full article